Christopher Morabito

Chief Medical Officer, Fulcrum Therapeutics (United States).

Companies

Catabasis PharmaceuticalsChief Medical Officer Jul 15, 2022 to now¹
Fulcrum Therapeutics (United States)Chief Medical Officer May 12, 2021 to Jan 21, 2022²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Catabasis Pharmaceuticals CATB0 shares³Apr 1, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Apr 1, 2024Sold 10,000 shares at $13.59 of Catabasis Pharmaceuticals³
Apr 1, 2024Exercised options 10,000 shares at $3.87 of Catabasis Pharmaceuticals³
Jan 29, 2024Sold 9,200 shares at $11.15 of Catabasis Pharmaceuticals⁴
Jan 29, 2024Exercised options 9,200 shares at $3.87 of Catabasis Pharmaceuticals⁴
Jan 26, 2024Sold 800 shares at $11.02 of Catabasis Pharmaceuticals⁴
Jan 26, 2024Exercised options 800 shares at $3.87 of Catabasis Pharmaceuticals⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCatabasis Pharmaceuticals, Chief Medical Officer
2
SEC EDGARFulcrum Therapeutics (United States), Chief Medical Officer
3
SEC EDGARCatabasis Pharmaceuticals shares after the filing of Apr 1, 2024
4
SEC EDGARForm 4 filed Jan 30, 2024